Key result
Direct mobilization after Angio-Seal yields ~46% access-site events, driven by hematomas with no major bleeding.
Why the study?
Routine postprocedural immobilization after transfemoral coronary procedures may delay recovery and prolong hospitalization, and its necessity is increasingly questioned with contemporary vascular closure devices. Evidence supporting direct mobilization after Angio-Seal VIP closure was limited, especially in patients receiving potent antithrombotic therapy or requiring larger sheath sizes.
Is direct mobilization after transfemoral coronary procedures using Angio-Seal VIP-mediated femoral artery closure safe and feasible in patients undergoing coronary angiography or PCI?
Observational (n=50)
Open-label
No
Is direct mobilization after transfemoral coronary procedures using Angio-Seal VIP-mediated femoral artery closure safe and feasible in patients undergoing coronary angiography or PCI?
Direct mobilization immediately after transfemoral coronary procedures using an Angio-Seal VIP closure device appears feasible without major bleeding (BARC ≥ 3) or major vascular complications, though minor/major hematomas occurred in 46% of patients.
Answers are grounded in this paper and cite their sources.
Immediate mobilization after Angio-Seal may be feasible but risks frequent minor hematomas; hypothesis-generating and should not change practice without randomized confirmation.
Background Routine postprocedural immobilization after transfemoral coronary procedures (TCPs) aims to prevent vascular complications but may delay recovery and prolong hospitalization. With contemporary vascular closure devices, the necessity of immobilization is increasingly questioned. The MOVE‐IT pilot study evaluated the safety and feasibility of direct mobilization after TCP using Angio‐Seal VIP–mediated femoral artery closure. This evaluation is relevant given the limited evidence supporting direct mobilization in contemporary TCP patients, especially those receiving increasingly potent antithrombotic therapy or undergoing procedures requiring larger sheath sizes. Methods This prospective, single‐center pilot study included 50 consecutive patients undergoing transfemoral coronary angiography (CAG) or percutaneous coronary intervention (PCI) using 6–8 Fr sheaths. Patients were mobilized directly after successful Angio‐Seal VIP deployment. The primary outcome was a composite endpoint of access‐site bleeding (BARC Types 2, 3, and 5), minor (< 5 cm) and major (≥ 5 cm) hematomas, vascular complications, vascular interventions, and vasovagal reactions. A stopping rule based on a 10% incidence of BARC Type 3 bleeding was incorporated. Secondary outcomes included time to discharge, patient satisfaction, and pain scores. Outcomes were assessed immediately after the procedure, at 1 and 2 h, and at 30‐day follow‐up. Results Mean age was 68.2 ± 9.1 years; 26% were female, and 50% underwent PCI. A 6 Fr sheath was used in 84% of patients. Mean arterial pressure before Angio‐Seal VIP deployment was 96.8 ± 2.3 mmHg. The median ACT was 228 s (IQR 198–264). The primary composite endpoint occurred in 23 patients (46%), comprising a total of 28 component events, predominantly driven by hematomas. Hematomas were observed in 23 patients, BARC Type 2 bleeding in 4 patients, and a vasovagal reaction in 1 patient. All BARC Type 2 bleeding events and the vasovagal reaction occurred in patients who also had a major hematoma. No BARC ≥ 3 bleedings, vascular complications, or vascular interventions occurred. Mean time to discharge was 3.0 ± 1.3 h. Patient‐reported outcomes showed high satisfaction (mean 9.0/10) and low pain scores (VAS < 1/10). Conclusions This small exploratory pilot study suggests that direct mobilization after TCP using Angio‐Seal VIP was feasible in this selected cohort, with no major bleeding or vascular complications observed, warranting further evaluation in comparative studies.
No takes yet. Share an insight, caveat, or question.
Jonkman et al. (2026) conducted an observational in Transfemoral coronary angiography or percutaneous coronary intervention (n=50). Direct mobilization after Angio-Seal VIP femoral artery closure was evaluated on Composite of access-site bleeding (BARC Types 2, 3, and 5), minor (<5 cm) and major (>=5 cm) hematomas, vascular complications, vascular interventions, and vasovagal reactions. Direct mobilization after Angio-Seal VIP femoral closure resulted in a 46% primary composite event rate (driven by hematomas), with 0% BARC >=3 bleeding or vascular complications.
Synapse has enriched 10 related papers. Consider them for comparative context: